Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2022

Platform to promote critical thought on India and British Indians.

Incorporated in March 2022

Origin: Oxford University, DPAG, Psychiatry

To improve the ESG outcomes of publicly traded corporations by enhancing the efficacy of shareholder ownership rights.

Incorporated in February 2022

Origin: Oxford University, Kellog College

Optical neural networks.

Incorporated in January 2022

Origin: Oxford University, Physics

2021

To develop new methodologies for single cell genomics.

Incorporated in December 2021

Origin: Oxford University, Weatherall Institute for Molecular Medicine

To develop and commercialise a rapid non-lab based diagnostic test for viral infections, with the first focus on Covid19.

Incorporated in December 2021

Origin: Oxford University, Physics

Oxford Global Guidance (OGG) is an online tool for providing guidance on medical device classification.

Incorporated in November 2021

Origin: Oxford University, Engineering

To provide data curation and maintenance services to commercial entities involved in carbon offset markets.

Incorporated in October 2021

Origin: Oxford University, Geography

To develop therapeutic antibodies.

Incorporated in October 2021

Origin: Oxford University, Medical Sciences

Machine learning algorithm and codes for quantum computers.

Incorporated in October 2021

Origin: Oxford University, Materials

To optimise the catalyst performance and highlight the advantages of a catalyst to create green fuel for the aviation sector through carbon capture.

Incorporated in August 2021

Origin: Oxford University, Chemistry

Development and characterisation of novel, first-in-class, selective and potential small molecule inhibitors targeting the YEATS Domain (YD) of MLLT1 and MLLT3.

Incorporated in August 2021

Origin: Oxford University, NDM, RDM, NDORMS

The company has been created by the Dementia Discovery Fund. The Company’s mission is to develop disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias.

Incorporated in July 2021

Origin: Oxford University, DPAG

To develop a bioelectronic platform with an initial focus on treating urinary incontinence.

Incorporated in June 2021

Origin: Oxford University, Engineering

LiliumX uses a unique protein technology platform to facilitate scalable discovery of first-in-class bispecific biologics

Incorporated in May 2021

Origin: Oxford University, Biochemistry

The technology consists of two patent families which collectively enable the development of cost effective, off-the-shelf vaccines based on a proprietary dendritic cell subset for the treatment of solid tumour cancers. The technology overcomes certain key roadblocks previously associated with dendritic cell vaccine technology.

Incorporated in March 2021

Origin: Oxford University, Sir William Dunn School of Pathology

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation